85 studies found for:    Open Studies | "Bone Diseases, Infectious"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-TNF Users (VERVE)
Conditions: Arthritis;   Rheumatoid Arthritis;   Psoriatic Arthritis;   Psoriasis;   Ankylosing Spondylitis;   Enteropathic Arthritis;   Crohn's Disease;   Inflammatory Arthritis
Intervention: Biological: Herpes Zoster Vaccine
2 Not yet recruiting Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
Conditions: Rheumatoid Arthritis;   Inflammatory Arthritis;   Arthritis;   Psoriatic Arthritis;   Psoriasis;   Ankylosing Spondylitis;   Enteropathic Arthritis;   Crohn's Disease
Interventions: Biological: Herpes Zoster Vaccine;   Drug: Placebo
3 Not yet recruiting Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA
Condition: Spondylitis, Ankylosing
Intervention: Biological: Etanercept
4 Recruiting Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo
Conditions: Axial Spondyloarthrithis;   Ankylosing Spondylitis
Interventions: Biological: Certolizumab Pegol;   Other: Placebo
5 Not yet recruiting AL-2 MP-1 (Polyimide) Acetabular Liner
Conditions: Osteoarthritis;   Avascular Necrosis;   Rheumatoid Arthritis;   Congenital Dysplasia of the Hip;   Ankylosing Spondylitis;   Post-traumatic; Arthrosis;   Injury of Hip
Intervention: Device: MP-1 Polymer on Ceramic Articulation system
6 Recruiting Biomarkers Identification of Anti-TNF α Agent's Efficacy in Ankylosing Spondylitis Patients
Condition: Ankylosing Spondylitis
Intervention: Drug: Adalimumab
7 Recruiting Etanercept Versus Adalimumab in the Treatment of Patients With Ankylosing Spondylitis. A Switch Study
Condition: Ankylosing Spondylitis
Interventions: Biological: Adalimumab;   Biological: Etanercept
8 Recruiting A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.
Conditions: Rheumatoid Arthritis;   Psoriatic Arthritis;   Axial Spondyloarthritis;   Plaque Psoriasis
Intervention: Drug: Etanercept
9 Recruiting The Optimal Duration of Preoperative Anti-tuberculosis Treatment of Spinal Tuberculosis
Condition: Tuberculosis, Spinal
Interventions: Drug: Isoniazid;   Drug: Rifampicin;   Drug: Ethambutol;   Drug: Pyrazinamide
10 Not yet recruiting Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes
Condition: Ankylosing Spondylitis
Interventions: Drug: NSAIDs;   Drug: anti-TNF
11 Not yet recruiting Phenomics in Autoimmune and Inflammatory Diseases
Conditions: Healthy Volunteer;   Rheumatoid Arthritis;   Ankylosing Spondylitis;   Systemic Lupus Erythematosus/Antiphospholipid Syndrome;   FMF;   Cryopyrin-Associated Periodic Syndromes /TNF-receptor Associated Periodic Syndrome;   Vasculitis;   Uveitis;   Myositis;   Crohn's Disease;   Ulcerative Rectocolitis;   Type 1 Diabetes;   Unclassified IAD Knee and/or Hip Arthritis, Muscular Dystrophy
Interventions: Other: 1: AID groups;   Other: 2: Control groups
12 Recruiting UT Southwestern Diabetic Foot Ulcers (DFU) and Osteomyelitis (DFO) Recruitment Database, Data and Tissue Repository
Conditions: Diabetic Foot Ulcers;   Osteomyelitis
Intervention: Other: DFU
13 Recruiting Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: TNF alpha;   Drug: NSAIDs and sulfasalazine
14 Not yet recruiting A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Participants With Active Radiographic Axial Spondyloarthritis
Condition: Axial Spondyloarthritis
Interventions: Drug: Placebo;   Drug: Ustekinumab 45 mg;   Drug: Ustekinumab 90 mg;   Drug: Golimumab 50 mg
15 Not yet recruiting A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Naive Participants With Active Radiographic Axial Spondyloarthritis
Condition: Axial Spondyloarthritis
Interventions: Drug: Placebo;   Drug: Ustekinumab 45 mg;   Drug: Ustekinumab 90 mg;   Drug: Golimumab 50 mg
16 Recruiting An Efficacy and Safety Study of Ustekinumab in Participants With Active Nonradiographic Axial Spondyloarthritis
Condition: Nonradiographic Axial Spondylitis, Ankylosing
Interventions: Drug: Group 1: Placebo;   Drug: Group 2: Ustekinumab 45 mg;   Drug: Group 3: Ustekinumab 90 mg
17 Not yet recruiting The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis
Conditions: Inflammatory Bowel Diseases;   Ankylosing Spondylitis
Interventions: Procedure: Pinch biopsies;   Procedure: Flexible sigmoidoscopy
18 Recruiting Efficacy of 0.2 % Digluconate Chlorhexidine Mouthwash for Preventing Alveolar Osteitis After Third Molar Extraction
Condition: Alveolar Osteitis
Interventions: Drug: DC071;   Drug: Placebo
19 Recruiting COMorbidities and EDucation in SPondyloArthritis Study
Condition: Axial Spondyloarthritis
Interventions: Behavioral: self-assessment/self-management;   Behavioral: Comorbidities (detection/prevention)
20 Recruiting Treatment of Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc Fusion Protein
Condition: Spondyloarthritis
Interventions: Drug: etanercept;   Drug: etanercept (half dose);   Drug: placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years